|
![]() |
|||
|
||||
OverviewClinical trials are the most definitive tool for evaluation of the applica- bility of clinical investigations. The main objective of clinical investiga- tions is to assess the potential value of a therapeutic entity in the treat- ment or prophylaxis of a disease or a condition. It is also deemed necessary at this stage to obtain information regarding the undesirable side effects, associated risks, and their interrelationship with clinical assessments. Most of these clinical investigations conform, in some form or fashion, to the guidelines adopted by the Food and Drug Administration (FDA) for a given class of compounds. Clinical investigations in the past have not included specific studies in special or subpopulations, e.g., the elderly. Because of an ever-increasing elderly population, newer policies for clinical investigations are now being debated with the recognition of enhanced drug sensitivity in this special population. This key research activity can lead not only to improved health care in the elderly but also to control of its costs. Full Product DetailsAuthor: N.R. Cutler , P.K. NarangPublisher: Springer Science+Business Media Imprint: Kluwer Academic/Plenum Publishers Edition: 1986 ed. Weight: 0.770kg ISBN: 9780306423116ISBN 10: 0306423111 Pages: 464 Publication Date: 31 December 1986 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Out of Print Availability: Out of stock ![]() Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |